Predictors of preterm birth in patients with mild systemic lupus erythematosus

被引:52
作者
Clowse, Megan E. B. [1 ]
Wallace, Daniel J. [2 ]
Weisman, Michael [2 ]
James, Andra [3 ]
Criscione-Schreiber, Lisa G. [1 ]
Pisetsky, David S. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Cedar Sinai Hosp, Dept Med, Los Angeles, CA USA
[3] Univ Virginia, Dept Obstet & Gynecol, Charlottesville, VA USA
关键词
Systemic Lupus Erythematosus; Disease Activity; Autoimmune Diseases; DISEASE-ACTIVITY; PREGNANCY;
D O I
10.1136/annrheumdis-2012-202449
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective While increased disease activity is the best predictor of preterm birth in women with systemic lupus erythematosus (SLE), even women with low disease activity are at increased risk of this complication. Biomarkers that would identify at-risk pregnancies could allow interventions to prevent preterm birth. Method Measures of SLE activity, inflammation, placental health and renal function between 20 and 28weeks gestation (mid-gestation) were correlated to preterm birth and gestational age at delivery in a prospective cohort of pregnant women with SLE. Result Of the 40 pregnancies in 39 women, all with mild-moderate SLE disease, 9 (23.7%) of the 38 live births were delivered preterm. Low C4 was the only marker of SLE activity associated with younger gestational age at delivery. Elevated ferritin and lower oestradiol correlated with younger gestational age at delivery. Renal function remained normal during all pregnancies at mid-gestation and did not correlate with preterm birth. Higher serum uric acid, however, correlated with younger gestational age at delivery. Conclusions In women with SLE with mild-moderate disease activity, ferritin, oestradiol and uric acid levels at mid-gestation may predict preterm birth. These markers may prove to be clinically useful in identifying pregnancies at particularly high risk for adverse outcomes.
引用
收藏
页码:1536 / 1539
页数:4
相关论文
共 13 条
[1]  
[Anonymous], BIRTHS FINAL DATA 20
[2]   PHYSIOLOGICAL ADAPTATIONS OF PREGNANCY [J].
BRANCH, DW .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1992, 28 (3-4) :120-122
[3]   Assessing disease activity in SLE patients during pregnancy [J].
Buyon, JP ;
Kalunian, KC ;
Ramsey-Goldman, R ;
Petri, MA ;
Lockshin, MD ;
Ruiz-Irastorza, G ;
Khamashta, M .
LUPUS, 1999, 8 (08) :677-684
[4]   The impact of increased lupus activity on obstetric outcomes [J].
Clowse, MEB ;
Magder, LS ;
Witter, F ;
Petri, M .
ARTHRITIS AND RHEUMATISM, 2005, 52 (02) :514-521
[5]   An overview of morbidity, mortality and long-term outcome of late preterm birth [J].
Dong, Ying ;
Yu, Jia-Lin .
WORLD JOURNAL OF PEDIATRICS, 2011, 7 (03) :199-204
[6]   Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus [J].
Doria, A ;
Cutolo, M ;
Ghirardello, A ;
Zampieri, S ;
Vescovi, F ;
Sulli, A ;
Giusti, M ;
Piccoli, A ;
Grella, P ;
Gambari, PF .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2002, 47 (02) :202-209
[7]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725
[8]   Estrogen and α-fetoprotein levels in maternal and umbilical cord blood samples in relation to birth weight [J].
Nagata, Chisato ;
Iwasa, Shinichi ;
Shiraki, Makoto ;
Shimizu, Hiroyuki .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (08) :1469-1472
[9]   A Systematic Review and Meta-Analysis of Pregnancy Outcomes in Patients with Systemic Lupus Erythematosus and Lupus Nephritis [J].
Smyth, Andrew ;
Oliveira, Guilherme H. M. ;
Lahr, Brian D. ;
Bailey, Kent R. ;
Norby, Suzanne M. ;
Garoyic, Vesna D. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (11) :2060-2068
[10]   Placental characteristics as a proxy measure of serum hormone and protein levels during pregnancy with a male fetus [J].
Trabert, Britton ;
Longnecker, Matthew P. ;
Graubard, Barry I. ;
Klebanoff, Mark A. ;
Stanczyk, Frank Z. ;
McGlynn, Katherine A. .
CANCER CAUSES & CONTROL, 2011, 22 (05) :689-695